- Home
- RVPH vs VGI Comparison
RVPH vs VGI Comparison
Compare RVPH & VGI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RVPH
- VGI
- Stock Information
- Founded
- RVPH 2006
- VGI 2012
- Country
- RVPH United States
- VGI United States
- Employees
- RVPH N/A
- VGI N/A
- Industry
- RVPH Biotechnology: Pharmaceutical Preparations
- VGI Investment Managers
- Sector
- RVPH Health Care
- VGI Finance
- Exchange
- RVPH Nasdaq
- VGI Nasdaq
- Market Cap
- RVPH 32.8M
- VGI N/A
- IPO Year
- RVPH N/A
- VGI N/A
- Fundamental
- Price
- RVPH $0.39
- VGI $7.80
- Analyst Decision
- RVPH Strong Buy
- VGI
- Analyst Count
- RVPH 5
- VGI 0
- Target Price
- RVPH $9.00
- VGI N/A
- AVG Volume (30 Days)
- RVPH 3.7M
- VGI 46.0K
- Earning Date
- RVPH 08-13-2025
- VGI 01-01-0001
- Dividend Yield
- RVPH N/A
- VGI 12.66%
- EPS Growth
- RVPH N/A
- VGI N/A
- EPS
- RVPH N/A
- VGI N/A
- Revenue
- RVPH N/A
- VGI N/A
- Revenue This Year
- RVPH N/A
- VGI N/A
- Revenue Next Year
- RVPH N/A
- VGI N/A
- P/E Ratio
- RVPH N/A
- VGI N/A
- Revenue Growth
- RVPH N/A
- VGI N/A
- 52 Week Low
- RVPH $0.30
- VGI $6.68
- 52 Week High
- RVPH $4.28
- VGI $7.99
- Technical
- Relative Strength Index (RSI)
- RVPH 35.22
- VGI 51.48
- Support Level
- RVPH $0.38
- VGI $7.82
- Resistance Level
- RVPH $0.45
- VGI $7.87
- Average True Range (ATR)
- RVPH 0.05
- VGI 0.06
- MACD
- RVPH 0.01
- VGI -0.01
- Stochastic Oscillator
- RVPH 17.57
- VGI 34.62
About RVPH Reviva Pharmaceuticals Holdings Inc.
Reviva Pharmaceuticals Holdings Inc is a late-stage pharmaceutical company that discovers, develops, and seeks to commercialize therapeutics for diseases. The current pipeline of the company focuses on the central nervous system, inflammatory, and cardiometabolic diseases. The company uses a chemical genomics-driven technology platform and proprietary chemistry to develop new medicines. The company's pipeline currently has two drug candidates, Brilaroxazine (RP5063) which is intended to treat multiple neuropsychiatric indications, including schizophrenia, bipolar disorder, depressive disorder, attention-deficit/hyperactivity disorder, behavioral and psychotic symptoms of dementia or Alzheimer's disease and Parkinson's disease psychosis and its other drug candidate is RP1208.